Related references
Note: Only part of the references are listed.Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras
Ki-Hyuk Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins
Akihide Yoshimi et al.
BLOOD (2011)
miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma
Hironori Matsuyama et al.
BLOOD (2011)
EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells
An De Weer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
The Evi1, microRNA-143, K-Ras axis in colon cancer
Jin-Song Gao et al.
FEBS LETTERS (2011)
Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia
Iria Vazquez et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Emerging complexity of microRNA generation cascades
Hiroshi I. Suzuki et al.
JOURNAL OF BIOCHEMISTRY (2011)
Claudin-18 Is an Early-Stage Marker of Pancreatic Carcinogenesis
Mariko Tanaka et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
The Oncoprotein EVI1 and the DNA Methyltransferase Dnmt3 Co-Operate in Binding and De Novo Methylation of Target DNA
Vitalyi Senyuk et al.
PLOS ONE (2011)
Evi1 forms a bridge between the epigenetic machinery and signaling pathways
Akihide Yoshimi et al.
ONCOTARGET (2011)
EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2
M. Gomez-Benito et al.
BRITISH JOURNAL OF CANCER (2010)
miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer
Shuangni Yu et al.
CANCER RESEARCH (2010)
Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
Yan Song et al.
CANCER RESEARCH (2010)
Significance of mucin expression in pancreatobiliary neoplasms
Suguru Yonezawa et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2010)
Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway
Hiroshi I. Suzuki et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
Ankur K. Nagaraja et al.
MOLECULAR ENDOCRINOLOGY (2010)
Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome
Jerome Dickstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
John P. Morris et al.
NATURE REVIEWS CANCER (2010)
Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies
Susumu Goyama et al.
CANCER SCIENCE (2009)
Ras Activity in Acinar Cells Links Chronic Pancreatitis and Pancreatic Cancer
Craig D. Logsdon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Ras Activity Levels Control the Development of Pancreatic Diseases
Baoan Ji et al.
GASTROENTEROLOGY (2009)
Modulation of microRNA processing by p53
Hiroshi I. Suzuki et al.
NATURE (2009)
Role of miR-143 targeting KRAS in colorectal tumorigenesis
X. Chen et al.
ONCOGENE (2009)
Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma
Kazuhiro Sentani et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia
De La O. Jean-Paul et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer
Kevin A. Kwei et al.
PLOS GENETICS (2008)
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
A. E. Szafranska et al.
ONCOGENE (2007)
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer
Meera Nanjundan et al.
CANCER RESEARCH (2007)
Evi1 is a survival factor which conveys resistance to both TGFb-β and taxol-mediated cell death via PI3K/AKT
Y. Liu et al.
ONCOGENE (2006)
Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues
XJ Ge et al.
GENOMICS (2005)
Matlnspector and beyond: promoter analysis based on transcription factor binding sites
K Cartharius et al.
BIOINFORMATICS (2005)
Pharmacologic inhibition of RAF→MEK→ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1
S Gysin et al.
CANCER RESEARCH (2005)
Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of hedgehog signaling on pancreatic ductal epithelial cells
NB Prasad et al.
CANCER RESEARCH (2005)
Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas
M Kitago et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
C Guerra et al.
CANCER CELL (2003)
Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas
GE Kim et al.
GASTROENTEROLOGY (2002)
The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling
K Izutsu et al.
BLOOD (2001)
The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death
M Kurokawa et al.
EMBO JOURNAL (2000)